“Investment Objective:
Benefit from rising healthcare spending, expanding pharma, medical devices, and hospital services.
Investment Rationale:
Rising Healthcare Demand Driven by Demographics and Income Growth: India’s increasing middle class and aging population are fueling sustained demand for healthcare services, pharmaceuticals, and medical devices, offering high growth and earning potential.
Expanding Healthcare Infrastructure and Government Support: Ongoing investments in hospitals, telemedicine, and health insurance schemes create a favorable environment for long-term sector growth.
Innovation and Technological Adoption: Advances in biotech, generic pharmaceuticals, and digital health solutions drive margin expansion and market share gains, positioning healthcare stocks for superior returns compared to other industries or asset classes.
Investment Methodology:
1. The broad universe for securities comprises of listed companies within the NSE 500 Index and all ETFs, which are meticulously filtered qualitatively in accordance with the predefined investment objective and investment rationale.
2. Proprietary algorithms, advanced quantitative models, and technical analysis are applied to systematically identify securities with the highest likelihood of delivering superior returns.
3. These models, extensively validated across various asset classes and time horizons, incorporate customized proprietary indicators of momentum, volume, volatility, and trend, ensuring that portfolio construction is entirely driven by objective data and high-quality signals, free from biases, prejudices, or emotional influence.
4. The selection of securities and their respective weightings within the model portfolio is further optimized based on factors including the target portfolio size, ETF allocation, average daily trading turnover, available investment capital, rebalancing frequency, as well as the number of quantitative and technical criteria met by each security.”


